Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature

Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of borte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharel, Prakash, Uprety, Deekchha, Chandra, Abhinav B., Hu, Yirui, Belur, Anuradha Avinash, Dhakal, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286773/
https://www.ncbi.nlm.nih.gov/pubmed/30595697
http://dx.doi.org/10.1155/2018/2913124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286773/
https://www.ncbi.nlm.nih.gov/pubmed/30595697
http://dx.doi.org/10.1155/2018/2913124

Ejemplares similares